ACADIA Pharmaceuticals Inc. vs Norfolk Southern Corporation — how do they compare? ACADIA Pharmaceuticals Inc. trades at $29.52 (market cap $5.07B), while Norfolk Southern Corporation trades at $334 (market cap $75.15B). The key difference: Norfolk Southern Corporation is far larger — about 14.8× ACADIA Pharmaceuticals Inc.'s market cap, and Norfolk Southern Corporation pays a 1.61% dividend while ACADIA Pharmaceuticals Inc. pays none. Which is the better fit depends on your goals.
| ACAD | NSC | |
|---|---|---|
Market Cap | $5.07B | $75.15B |
Sector | Health | Technology |
52-Week High | $29.41 | $350.66 |
52-Week Low | $20.06 | $272.35 |
Enterprise Value | $4.19B | $90.70B |
Dividend Yield | — | 1.61% |
Trailing returns across standard periods
Latest headlines on both assets
Acadia Pharmaceuticals is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecule drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.
Read more on ACAD →Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →